Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (s)-(1-2-chlorophenyl)-1,2-ethanediol 2-carbamate
2. Rwj 333369
3. Rwj-333369
4. Rwj333369
5. S-2-o-carbamoyl-1-o-chlorophenyl-ethanol
1. Rwj-333369
2. 194085-75-1
3. Ykp-509
4. Jnj-10234094
5. Carisbamate (usan)
6. Carisbamate [usan]
7. (s)-carisbamate
8. P7725i9v3z
9. Rwj-333369-000
10. (s)-2-(2-chlorophenyl)-2-hydroxyethyl Carbamate
11. (2s)-2-(2-chlorophenyl)-2-hydroxyethyl Carbamate
12. (+)-(2s)-2-(2-chlorophenyl)-2-hydroxyethyl Carbamate
13. 1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (1s)-
14. 1,2-ethanediol,1-(2-chlorophenyl)-, 2-carbamate, (1s)-
15. Comfyde
16. Rwj 333369
17. Carisbamate [usan:inn]
18. S-2-o-carbamoyl-1-o-chlorophenyl-ethanol
19. Unii-p7725i9v3z
20. [(2s)-2-(2-chlorophenyl)-2-hydroxyethyl] Carbamate
21. Carisbamate [mi]
22. Carisbamate [inn]
23. Carisbamate [who-dd]
24. Schembl729003
25. Chembl2087003
26. Dtxsid70426076
27. Chebi:135966
28. Zinc30691363
29. Db12338
30. Hy-14948
31. (s)-2-carbamoyloxy-1-o-chlorophenylethanol
32. Cs-0003652
33. D06573
34. (s)-2-o-carbamoyl-1-o-chlorophenyl-ethanol
Molecular Weight | 215.63 g/mol |
---|---|
Molecular Formula | C9H10ClNO3 |
XLogP3 | 1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 215.0349209 g/mol |
Monoisotopic Mass | 215.0349209 g/mol |
Topological Polar Surface Area | 72.6 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 201 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Infantile spasms (West Syndrome), Lennox-Gastaut Syndrome, Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, Neonatal seizures, Other paediatric epilepsy syndromes such as Dravet Syndrome, myoclonic astatic syndrome, epilepsy with continuous sharp-waves in sleep, idiopathic partial epilepsy, absence epilepsy
N - Nervous system
N03 - Antiepileptics
N03A - Antiepileptics
N03AX - Other antiepileptics
N03AX19 - Carisbamate
ABOUT THIS PAGE
19
PharmaCompass offers a list of Carisbamate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carisbamate manufacturer or Carisbamate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carisbamate manufacturer or Carisbamate supplier.
PharmaCompass also assists you with knowing the Carisbamate API Price utilized in the formulation of products. Carisbamate API Price is not always fixed or binding as the Carisbamate Price is obtained through a variety of data sources. The Carisbamate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL, including repackagers and relabelers. The FDA regulates (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL supplier is an individual or a company that provides (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL active pharmaceutical ingredient (API) or (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL finished formulations upon request. The (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL suppliers may include (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL API manufacturers, exporters, distributors and traders.
click here to find a list of (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL DMF (Drug Master File) is a document detailing the whole manufacturing process of (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL active pharmaceutical ingredient (API) in detail. Different forms of (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL DMFs exist exist since differing nations have different regulations, such as (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL DMF submitted to regulatory agencies in the US is known as a USDMF. (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL USDMF includes data on (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL suppliers with USDMF on PharmaCompass.
(S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL GMP manufacturer or (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL GMP API supplier for your needs.
A (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL CoA (Certificate of Analysis) is a formal document that attests to (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL's compliance with (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL specifications and serves as a tool for batch-level quality control.
(S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL CoA mostly includes findings from lab analyses of a specific batch. For each (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
(S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL may be tested according to a variety of international standards, such as European Pharmacopoeia ((S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL EP), (S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL JP (Japanese Pharmacopeia) and the US Pharmacopoeia ((S)-2-O-CARBAMOYL-1-O-CHLOROPHENYL-ETHANOL USP).